XTX Topco’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$228K Sell
11,362
-10,487
-48% -$210K 0.01% 1620
2025
Q1
$430K Buy
+21,849
New +$430K 0.02% 1134